Skip to main content
See every side of every news story
Published loading...Updated

Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call

Summary by The Manila Times
RICHMOND, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the company has scheduled the...

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Manila Times broke the news in Manila, Philippines on Thursday, October 30, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal